Yes, IMU won't be worth billions for only this market but the VAXINIA clinical trial is open to all solid cancers and that's were BP will see very significant growth of the IP and pay much more not just for the cholangiocarcinoma market but many other solid cancer market and these other tumours might need CD19 to work.....who knows, that's why IMU is conducting the OASIS clinical trials.
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)